Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. AKAM
2. COST
3. SPY
4. META
5. ZS
6. DRI
7. ULS
8. NVDA
9. PRME
10. CRL

Go back to Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
(NASDAQ: AKTX) Delayed: 9.77 -0.29 (2.88%)
Previous Close $10.06    52 Week High $19.75 
Open $10.25    52 Week Low $7.63 
Day High $10.25    P/E N/A 
Day Low $9.77    EPS $0.00 
Volume 3,369       

(NASDAQ: AKTX) Delayed: 9.77 -0.29 (2.88%)
Previous Close $10.06    52 Week High $19.75 
Open $10.25    52 Week Low $7.63 
Day High $10.25    P/E N/A 
Day Low $9.77    EPS $0.00 
Volume 3,369